To further uncover the actions of SELENBP1 in human NSCLC cells, the stable SELENBP1‐overexpressing A549 and H1299 cell lines were established (named A549‐SELENBP1 and H1299‐SELENBP1), and the expression levels of SELENBP1 were quantified by qRT‐PCR and western blotting (Figure 2B). Here, SELENBP1 is linked to non-small cell lung carcinoma.